查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552598

美國下肢靜脈曲張治療設備市場：2024-2030年按類型、佔有率、趨勢分析報告、按細分市場預測的市場規模

U.S. Varicose Vein Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation/ Stripping), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 75 Pages | 商品交期: 2-10個工作天內

價格

美國靜脈曲張治療設備市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，美國靜脈曲張治療器材市場規模預計將達到7.951億美元，2024年至2030年的複合年成長率為5.5%。

由於肥胖、懷孕、久坐的生活方式和長時間站立等身體活動等危險因素導致的靜脈曲張患病率較高，預計將推動市場成長。

由於年齡成長以及高血壓、靜脈血栓症等疾病的發病等因素，60歲以上人口靜脈疾病盛行率高達26%。 0至17歲族群中發生率最低，為17%，主要原因是遺傳、肥胖以及影響動脈及靜脈的文明病等危險因子。

由於持續的研發活動，技術不斷進步預計將推動靜脈曲張治療設備市場的發展。主要市場參與者正在進行的許多臨床試驗正在研究新系統相對於傳統治療方法的使用，以獲得相對於現有設備的競爭優勢。這提高了進入市場的產品品質並增加了市場競爭。例如，2019年6月，華盛頓湖血管中心針對接受Venaseal和靜脈內熱消融治療的有症狀靜脈曲張患者進行了一項研究。

2015年，美國在手術和非手術整容手術上總共花費了135億美元。自2011年以來，非手術治療的比例增加了44%，佔整容手術總支出的42%。這些統計數據強調，靜脈曲張治療設備市場對於美容目的具有吸引力。

美國靜脈曲張治療設備市場報告亮點：

  • 按類型分類，硬化療法將在 2023 年佔據最大的市場佔有率。
  • 醫療保險為靜脈曲張的硬化療法提供承保，因此醫療保健提供者和患者的採用率很高。
  • 在美國靜脈曲張治療設備市場運作的主要企業包括 Medtronic plc、AngioDynamics, Inc.、Biolitec AG、Lumenis Ltd.、Syneron Medical Ltd.、Energist Group、Eufoton srl、Quanta Systems SpA、Teleflex , Inc.。
  • 2015 年 2 月，Medtronic（當時稱為 Covidien）的新產品 VenaSeal 封閉系統獲得美國食品藥物管理局(FDA) 的上市前核准。該系統是微創的，使用醫用黏劑來閉合患有靜脈疾病的患者受損的靜脈。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析

第4章按類型分類的業務分析

  • 類型細分儀表板
  • 美國靜脈曲張治療設備市場類型變化分析
  • 2018-2030年美國下肢靜脈曲張治療設備市場規模及趨勢分析（依類型）
  • 靜脈消融
    • 2018-2030 年靜脈消融市場估計與預測
    • 靜脈雷射治療
    • 射頻消融術
  • 硬化療法
    • 2018-2030 年硬化療法市場估計與預測
  • 手術結紮/剝離
    • 2018-2030年手術結紮/剝離市場估計與預測

第5章競爭狀況

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Medtronic
    • AngioDynamics
    • Candela Corporation
    • Lumenis Be Ltd.
    • biolitec Holding GmbH &Co KG
    • Eufoton srl
    • Energist
    • Teleflex Incorporated
Product Code: GVR-4-68038-116-0

U.S. Varicose Vein Treatment Devices Market Growth & Trends:

The U.S. varicose vein treatment devices market size is expected to reach USD 795.1 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as obesity, pregnancy, sedentary lifestyle, and physical activities like standing for longer durations is expected to drive the market growth.

The prevalence of vein diseases is high in population above 60 years at 26%, owing to the factors such as increasing age and development of conditions like hypertension and venous thrombosis. The incidence is lowest in the age group of 0 to 17 at 17% and is majorly due to the risk factors such as genetics, obesity, and lifestyle-related disorders affecting the arteries and veins.

Increasing technological advancements due to continuous R&D activities are anticipated to drive the market for varicose vein treatment devices. Many ongoing clinical trials conducted by the key market players study the use of novel systems over traditional treatment methods to gain a competitive edge over the existing devices. This increases competition in the market enhancing the quality of products introduced in the market. For instance, in June 2019, the Lake Washington Vascular Centre conducted a study based on patients with symptomatic varicose veins treated with Venaseal and Endovenous Thermal Ablation.

The total expenditure of Americans on combined surgical and nonsurgical cosmetic procedures was USD 13.5 billion in 2015. The percentage of nonsurgical procedures has grown by 44% since 2011 and accounted for 42% of the total expenditure done on cosmetic procedures. These statistics highlight that the market for varicose vein treatment devices is attractive for cosmetics purposes.

U.S. Varicose Vein Treatment Devices Market Report Highlights:

  • Based on type, sclerotherapy accounted for the largest market share in 2023
  • Medicare offers insurance for sclerotherapy procedures for varicose veins, resulting in its high adoption by the healthcare providers and patients
  • Some of the key players operating in the U.S. varicose vein treatment devices market are Medtronic plc; AngioDynamics, Inc.; Biolitec AG; Lumenis Ltd.; Syneron Medical Ltd.; Energist Group; Eufoton srl; Quanta Systems S.p.A.; and Teleflex, Inc.
  • In February 2015, Medtronic (then Covidien) received a pre-market approval from the U.S. Food and Drug Administration (FDA) for their new product, VenaSeal closure system-a minimally invasive and uses a medical adhesive to close the damaged vein in patients with vein diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing preference for minimally invasive treatment procedures
      • 3.2.1.2. Introduction of technologically advanced devices
      • 3.2.1.3. Increasing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procedural costs and inconsistent reimbursement structure
      • 3.2.2.2. Risk factors associated with varicose veins treatment
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Varicose Vein Treatment Devices Market Type Movement Analysis
  • 4.3. U.S. Varicose Vein Treatment Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Endovenous Ablation
    • 4.4.1. Endovenous ablation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Endovenous laser therapy
      • 4.4.2.1. Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Radiofrequency ablation
      • 4.4.3.1. Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Sclerotherapy
    • 4.5.1. Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Surgical Ligation/Stripping
    • 4.6.1. Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

  • 5.1. Company Categorization
  • 5.2. Strategy Mapping
  • 5.3. Company Market Position Analysis, 2023
  • 5.4. Company Profiles/Listing
    • 5.4.1. Medtronic
      • 5.4.1.1. Overview
      • 5.4.1.2. Financial Performance
      • 5.4.1.3. Product Benchmarking
      • 5.4.1.4. Strategic Initiatives
    • 5.4.2. AngioDynamics
      • 5.4.2.1. Overview
      • 5.4.2.2. Product Benchmarking
      • 5.4.2.3. Strategic Initiatives
    • 5.4.3. Candela Corporation
      • 5.4.3.1. Overview
      • 5.4.3.2. Financial Performance
      • 5.4.3.3. Product Benchmarking
      • 5.4.3.4. Strategic Initiatives
    • 5.4.4. Lumenis Be Ltd.
      • 5.4.4.1. Overview
      • 5.4.4.2. Product Benchmarking
      • 5.4.4.3. Strategic Initiatives
    • 5.4.5. biolitec Holding GmbH & Co KG
      • 5.4.5.1. Overview
      • 5.4.5.2. Product Benchmarking
      • 5.4.5.3. Strategic Initiatives
    • 5.4.6. Eufoton s.r.l.
      • 5.4.6.1. Overview
      • 5.4.6.2. Financial Performance
      • 5.4.6.3. Product Benchmarking
      • 5.4.6.4. Strategic Initiatives
    • 5.4.7. Energist
      • 5.4.7.1. Overview
      • 5.4.7.2. Financial Performance
      • 5.4.7.3. Product Benchmarking
      • 5.4.7.4. Strategic Initiatives
    • 5.4.8. Teleflex Incorporated
      • 5.4.8.1. Overview
      • 5.4.8.2. Financial Performance
      • 5.4.8.3. Product Benchmarking
      • 5.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. varicose vein treatment devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 Key companies undergoing expansions.
  • Table 5 Key companies undergoing acquisitions.
  • Table 6 Key companies undergoing collaborations.
  • Table 7 Key companies launching new products/services.
  • Table 8 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. varicose vein treatment devices market: market outlook
  • Fig. 7 U.S. varicose vein treatment devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. varicose vein treatment devices market driver impact
  • Fig. 10 U.S. varicose vein treatment devices market restraint impact: Type movement analysis
  • Fig. 11 U.S. varicose vein treatment devices market: Type outlook and key takeaways
  • Fig. 12 Endovenous Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Market share of key market players - U.S. varicose vein treatment devices market